6-132322698-T-C
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_015529.4(MOXD1):c.1286A>G(p.Glu429Gly) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: not found (cov: 32)
Consequence
MOXD1
NM_015529.4 missense
NM_015529.4 missense
Scores
2
10
7
Clinical Significance
Conservation
PhyloP100: 4.60
Genes affected
MOXD1 (HGNC:21063): (monooxygenase DBH like 1) Predicted to enable copper ion binding activity and dopamine beta-monooxygenase activity. Predicted to be involved in dopamine catabolic process; norepinephrine biosynthetic process; and octopamine biosynthetic process. Part of endoplasmic reticulum membrane. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MOXD1 | NM_015529.4 | c.1286A>G | p.Glu429Gly | missense_variant | 8/12 | ENST00000367963.8 | NP_056344.2 | |
MOXD1 | XM_017010714.3 | c.1181A>G | p.Glu394Gly | missense_variant | 8/12 | XP_016866203.1 | ||
MOXD1 | XM_047418621.1 | c.1025A>G | p.Glu342Gly | missense_variant | 8/12 | XP_047274577.1 | ||
MOXD1 | XM_047418622.1 | c.1025A>G | p.Glu342Gly | missense_variant | 8/12 | XP_047274578.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MOXD1 | ENST00000367963.8 | c.1286A>G | p.Glu429Gly | missense_variant | 8/12 | 1 | NM_015529.4 | ENSP00000356940.3 | ||
MOXD1 | ENST00000336749.3 | c.1082A>G | p.Glu361Gly | missense_variant | 7/11 | 1 | ENSP00000336998.3 | |||
MOXD1 | ENST00000489128.1 | n.408A>G | non_coding_transcript_exon_variant | 3/5 | 3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome Cov.: 31
GnomAD4 exome
Cov.:
31
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 17, 2024 | The c.1286A>G (p.E429G) alteration is located in exon 8 (coding exon 8) of the MOXD1 gene. This alteration results from a A to G substitution at nucleotide position 1286, causing the glutamic acid (E) at amino acid position 429 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Uncertain
T;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D
M_CAP
Benign
D
MetaRNN
Uncertain
D;D
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;.
PrimateAI
Benign
T
PROVEAN
Pathogenic
D;D
REVEL
Benign
Sift
Uncertain
D;D
Sift4G
Uncertain
D;D
Polyphen
P;D
Vest4
MutPred
Loss of solvent accessibility (P = 0.0769);.;
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.